Study Name: Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
12 locations found
- GSK Investigational Site
Location: Fairfield, Connecticut 06824
- GSK Investigational Site
Location: Miami, Florida 33136
- GSK Investigational Site
Location: Sunrise, Florida 33351
- GSK Investigational Site
Location: West Palm Beach, Florida 33407
- GSK Investigational Site
Location: Atlanta, Georgia 30327
- GSK Investigational Site
Location: Philadelphia, Pennsylvania 19107
- GSK Investigational Site
Location: Cullman, Alabama 35058
- GSK Investigational Site
Location: Fullteron, California 92835
- GSK Investigational Site
Location: Tampa, Florida 33612
- GSK Investigational Site
Location: Northbrook, Illinois 60062
- GSK Investigational Site
Location: Grand Rapids, Michigan 49503
- GSK Investigational Site
Location: Seattle, Washington 98122
|